Time to and cumulative incidence of TRM among patients randomized to treatment with busulfan (Bu) or TBI for early disease (first remission or first chronic phase) or late disease (later stages). The difference was significant for Bu late versus TBI late (P = .004) and Bu late versus Bu early or TBI early (P < .001).